Clinical Report: Scaling Diabetic Eye Care in Vietnam
Overview
A new partnership between Orbis and Roche Pharma aims to enhance diabetic retinopathy care in Vietnam, targeting approximately 27,000 individuals. The initiative will improve screening, referral, and treatment services while generating data to inform national guidelines.
Background
Diabetic retinopathy is a leading cause of avoidable blindness, particularly among working-age individuals in Vietnam, where diabetes prevalence is rising. With an estimated seven million people living with diabetes in the country, there is an urgent need for improved eye care infrastructure and services. This initiative represents a significant step towards addressing the growing burden of diabetic eye disease.
Data Highlights
No numerical data available in the source material.
Key Findings
- The Vietnam Eye Health Program aims to scale up diabetic eye care services across seven hospitals.
- Approximately 27,000 individuals with diabetic eye disease will benefit from enhanced screening and treatment.
- AI-assisted screening will be introduced through Orbis’s Cybersight telemedicine platform.
- The program will provide advanced diagnostic tools and training for healthcare professionals.
- Real-world data generated will help develop national guidelines for diabetic retinopathy management.
Clinical Implications
Healthcare professionals should be aware of the new resources and training opportunities available through this partnership. Early detection and timely intervention for diabetic retinopathy are critical in preventing vision loss, and this initiative aims to strengthen the overall diabetic eye care framework in Vietnam.
Conclusion
The collaboration between Orbis and Roche Pharma represents a proactive approach to combatting diabetic retinopathy in Vietnam, with the potential to significantly reduce preventable blindness in the population.
Related Resources & Content
- Retinal Physician, Retinal Physician, 2019 -- Engaging Staff in Diabetic Eye Care
- Retinal Physician, Retinal Physician, 2016 -- The Looming Unmet Need in Diabetic Eye Care
- Optometric Management, Optometric Management, 2022 -- Keep Tabs on Diabetes
- People with diabetes in Vietnam rise, seven million sufferers documented
- Retinal Physician — The Socioeconomics of Diabetic Retinopathy
- People with diabetes in Vietnam rise, seven million sufferers documented
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial - PMC
- Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis | npj Digital Medicine
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
